Compass Pathways Plc (CMPS)
11.90
-0.05
(-0.42%)
USD |
NASDAQ |
Oct 02, 16:00
11.91
+0.01
(+0.08%)
After-Hours: 20:00
Compass Pathways Enterprise Value : 1.236B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.236B |
| October 01, 2026 | 1.243B |
| September 30, 2026 | 1.309B |
| September 29, 2026 | 1.380B |
| September 28, 2026 | 1.417B |
| September 25, 2026 | 1.393B |
| September 24, 2026 | 1.398B |
| September 23, 2026 | 1.487B |
| September 22, 2026 | 1.627B |
| September 21, 2026 | 1.658B |
| September 18, 2026 | 1.683B |
| September 17, 2026 | 1.657B |
| September 16, 2026 | 1.494B |
| September 15, 2026 | 1.495B |
| September 14, 2026 | 1.594B |
| September 11, 2026 | 1.569B |
| September 10, 2026 | 1.551B |
| September 09, 2026 | 1.680B |
| September 08, 2026 | 1.526B |
| September 04, 2026 | 1.422B |
| September 03, 2026 | 1.425B |
| September 02, 2026 | 1.417B |
| September 01, 2026 | 1.418B |
| August 31, 2026 | 1.455B |
| August 28, 2026 | 1.484B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.608B |
| August 26, 2026 | 1.604B |
| August 25, 2026 | 1.640B |
| August 24, 2026 | 1.548B |
| August 21, 2026 | 1.430B |
| August 20, 2026 | 1.497B |
| August 19, 2026 | 1.522B |
| August 18, 2026 | 1.507B |
| August 17, 2026 | 1.483B |
| August 14, 2026 | 1.446B |
| August 13, 2026 | 1.425B |
| August 12, 2026 | 1.551B |
| August 11, 2026 | 1.437B |
| August 10, 2026 | 1.410B |
| August 07, 2026 | 1.459B |
| August 06, 2026 | 1.460B |
| August 05, 2026 | 1.464B |
| August 04, 2026 | 1.222B |
| August 03, 2026 | 1.148B |
| July 31, 2026 | 1.161B |
| July 30, 2026 | 1.191B |
| July 29, 2026 | 1.100B |
| July 28, 2026 | 1.093B |
| July 27, 2026 | 1.150B |
| July 24, 2026 | 1.149B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Silence Therapeutics Plc | 495.01M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -20.30M |
| Mereo BioPharma Group Plc | 31.54M |
| HemoGenyx Pharmaceuticals Plc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -254.25M |
| Total Expenses (Quarterly) | 254.25M |
| EPS Diluted (Quarterly) | -1.883 |
| Earnings Yield | -38.86% |
| Normalized Earnings Yield | -27.18 |